4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-018981
See Remarks sold 2,209 shares at an average $13.18 ($29,116)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McNeill Jonathan See Remarks | 2023-03-13 | Sale | −1,000 | $13.00 | $13,000 | 66,600 | D |
| McNeill Jonathan See Remarks | 2023-03-14 | Sale | −1,209 | $13.33 | $16,116 | 65,391 | D |
| Open-market sales · 2,209 sh · avg $13.18 · $29,116 | |||||||
Loading xslF345X03/doc4.xml…